Try our Advanced Search for more refined results
December 23, 2016
In re Propranolol Antitrust Litigation
Case Number:
1:16-cv-09901
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Gibson Dunn
- Girard Sharp
- Hagens Berman
- Kaplan Fox
- Kasowitz Benson
- Kirkland & Ellis
- Latham & Watkins
- Lieff Cabraser
- Morgan Lewis
- Nussbaum Law Group
- O'Melveny & Myers
- Safirstein Law
- Saxena White
- Vanek Vickers
- Williams & Connolly
- Wilson Sonsini
Companies
- Allergan PLC
- American Federation of State County & Municipal Employees
- Avet Pharmaceuticals Inc.
- Endo International PLC
- Par Pharmaceutical Cos. Inc.
- Teva Pharmaceutical Industries Ltd.
- Upsher-Smith Laboratories Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 07, 2017
Teva, Others Must Face Blood Pressure Drug Antitrust Suit
Teva, Mylan, Heritage Pharmaceuticals and other generic-drug manufacturers can't dodge antitrust claims accusing them of conspiring to massively increase the price of propranolol hydrochloride, a generic blood pressure medication, a New York federal judge said Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login